In our study, the expression of this antigen-presentation (HLA-DR) receptor was not significantly different between severe COVID-19 groups (p = 0.07), although we found a negative association between this surface receptor on CD14+ monocytes and both total leukocytes and circulating neutrophils exclusively in patients with obesity (Figure 4). The gene discussed is CD14; the disease is Obesity.